Curaleaf Holdings (CURLF) Asset Writedowns and Impairment (2021 - 2025)
Curaleaf Holdings (CURLF) posted quarterly Asset Writedowns and Impairment of $4.3 million for Q4 2025, up 481.84% year-over-year from $740922.4 in Q4 2024, and up 608.37% quarter-over-quarter from -$848000.0 in Q3 2025.
Curaleaf Holdings (CURLF) Asset Writedowns and Impairment (2021 - 2025) Analysis & Trends
Curaleaf Holdings' Asset Writedowns and Impairment history runs 4 years deep, the most recent figure standing at $4.3 million for Q4 2025.
- In Q4 2025, Asset Writedowns and Impairment rose 481.84% year-over-year to $4.3 million; the TTM figure through Dec 2025 stood at $1.7 million (down 58.98% YoY), while the FY2025 annual figure was $977000.0, up 135.99% from the prior year.
- Asset Writedowns and Impairment for Q4 2025 stood at $4.3 million, up from -$848000.0 in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $9.2 million in Q4 2021, with the low at -$1.1 million in Q4 2024.
- The 4-year median for Asset Writedowns and Impairment is -$301000.0 (2023), against an average of $2.4 million.
- The sharpest annual moves came in 2024 and 2025: Asset Writedowns and Impairment slumped 118.22% in 2024, then jumped 481.84% in 2025.
- Curaleaf Holdings' Asset Writedowns and Impairment stood at $9.2 million in 2021, then sank by 32.64% to $6.2 million in 2023, then sank by 118.22% to -$1.1 million in 2024, then surged by 481.84% to $4.3 million in 2025.
- Business Quant data shows CURLF's Asset Writedowns and Impairment at $4.3 million in Q4 2025, -$848000.0 in Q3 2025, and -$1.1 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Curaleaf Holdings | 2.48 Bn | 2.38 Bn | 169.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.31 Mn |
| Dec 31, 2025 | 4.31 Mn |
| Sep 30, 2025 | -848,000.00 |
| Sep 30, 2025 | -848,000.00 |
| Dec 31, 2024 | -1.13 Mn |
| Dec 31, 2024 | -1.13 Mn |
| Sep 30, 2024 | -642,000.00 |
| Sep 30, 2024 | -642,000.00 |
| Dec 31, 2023 | 6.20 Mn |
| Dec 31, 2023 | 6.20 Mn |
| Sep 30, 2023 | -301,000.00 |
| Sep 30, 2023 | -301,000.00 |
| Dec 31, 2021 | 9.20 Mn |
| Dec 31, 2021 | 9.20 Mn |